Recombinant Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)
![Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)](https://www.abcam.com/ps/products/195/ab195117/Images/ab195117-284907-anti-rip3-phospho-s232-antibody-epr9516n-25-western-blot.jpg "Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)")
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR9516(N)-25] to RIP3 (phospho S232)
- Suitable for: ELISA, WB, Dot blot
- Reacts with: Mouse, Human
Overview
-
Product name
Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25]
See all RIP3 primary antibodies -
Description
Rabbit monoclonal [EPR9516(N)-25] to RIP3 (phospho S232) -
Host species
Rabbit -
Tested applications
Suitable for: ELISA, WB, Dot blotmore details -
Species reactivity
Reacts with: Mouse, Human -
Immunogen
This information is proprietary to Abcam and/or its suppliers.
-
Positive control
- WB: L-929 whole cell lysate treated with 20 ng/ml TNF alpha,100 nM Smac mimetic, and 20 µM z-VAD for 8 h and then harvested; Untreated L-929 whole cell lysate; TSE (WT) whole cell lysate treated with 20 ng/ml TNF alpha,100 nM Smac mimetic, and 20 µM z-VAD for 12 h and then harvested; TSE (KO MLKL) whole cell lysate treated with 20 ng/ml TNF alpha,100 nM Smac mimetic, and 20 µM z-VAD for 12 h and then harvested.
-
General notes
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol, 0.05% BSA -
Concentration information loading... -
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
EPR9516(N)-25 -
Isotype
IgG -
Research areas
Associated products
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
-
Related Products
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab195117 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| ELISA |
Use at an assay dependent concentration.
|
|
| WB | (6) |
1/1000. Detects a band of approximately 53 kDa (predicted molecular weight: 53 kDa).
|
| Dot blot |
Use at an assay dependent concentration.
|
| Notes |
|---|
|
ELISA
Use at an assay dependent concentration. |
|
WB
1/1000. Detects a band of approximately 53 kDa (predicted molecular weight: 53 kDa). |
|
Dot blot
Use at an assay dependent concentration. |
Target
-
Function
Promotes apoptosis. -
Tissue specificity
Detected at lower levels in heart, placenta, lung and kidney. Isoform 3 is significantly increased in colon and lung cancers. -
Sequence similarities
Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family.
Contains 1 protein kinase domain. -
Post-translational
modificationsAutophosphorylated. -
Cellular localization
Cytoplasm. - Information by UniProt
-
Database links
- Entrez Gene: 11035 Human
- Entrez Gene: 56532 Mouse
- Omim: 605817 Human
- SwissProt: Q9Y572 Human
- SwissProt: Q9QZL0 Mouse
- Unigene: 268551 Human
- Unigene: 46612 Mouse
-
Alternative names
- Receptor interacting protein 3 antibody
- Receptor interacting serine threonine kinase 3 antibody
- Receptor interacting serine/threonine protein kinase 3 antibody
see all
Images
-
Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)All lanes : Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117) at 1/10000 dilution
Lane 1 : Untreated L-929 (Mouse connective tissue fibroblast cell line) whole cell lysate
Lane 2 : L-929 (Mouse connective tissue fibroblast cell line) whole cell lysate treated with phosphatase
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 53 kDa
Observed band size: 53 kDa
Exposure time: 3 minutesBlocking/Dilution buffer: 5% NFDM/TBST.
-
![Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)](https://www.abcam.com/ps/products/195/ab195117/Images/ab195117-257717-anti-rip3-phospho-s232-antibody-epr9516n-25-western-blot.jpg)
Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)All lanes : Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117) at 1/2000 dilution
Lane 1 : Untreated TSE (WT) whole cell lysate
Lane 2 : TSE (WT) whole cell lysate treated with 20 ng/ml TNF alpha,100 nM Smac mimetic, and 20 µM z-VAD for 12 h and then harvested
Lane 3 : Untreated TSE (KO RIP3) whole cell lysate
Lane 4 : TSE (KO RIP3) whole cell lysate treated with 20 ng/ml TNF alpha,100 nM Smac mimetic, and 20 µM z-VAD for 12 h and then harvested
Lane 5 : Untreated TSE (KO MLKL) whole cell lysate
Lane 6 : TSE (KO MLKL) whole cell lysate treated with 20 ng/ml TNF alpha,100 nM Smac mimetic, and 20 µM z-VAD for 12 h and then harvested
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/1000 dilution
Predicted band size: 53 kDa
Observed band size: 53 kDa
Exposure time: 30 secondsBlocking/Dilution buffer: 5% NFDM/TBST.
Lysates were provided by Xiaodong Wang, National Institute of Biological Sciences, Beijing
-
![Dot Blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)](https://www.abcam.com/ps/products/195/ab195117/Images/ab195117-258254-anti-rip3-phospho-s232-antibody-epr9516n-25-dot-blot.jpg)
Dot Blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)Primary antibody: ab195117 at 1:1000 dilution (1.6μg/ml), secondary antibody: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1:1000 dilution, Blocking and dilution buffer: 5% NFDM/TBST, Lane 1: RIP3 (phospho S232) phospho peptide, Lane 2: RIP3 Non-phospho peptide, Exposure time: 3 minutes.
We observed weak binding to the non-phospho peptide at very high concentrations.
-
![ELISA - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)](https://www.abcam.com/ps/products/195/ab195117/Images/ab195117-258156-anti-rip3-phospho-s232-antibody-epr9516n-25-elisa.jpg)
ELISA - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)Serially diluted ab195117 was bound to immobilized phospho or non-phospho (control) peptide demonstrating minimal cross-reactivity to the non-phosphorylated residue. Antigen - RIP3 (phospho S232) phospho peptide;RIP3 non-phospho peptide at 250 ng/ml. Primary antibody concentration range: 0 - 500 ng/ml. Secondary antibody - Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) at 1:2500.
-
![Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)](https://www.abcam.com/ps/products/195/ab195117/Images/ab195117-8-benefits-of-recombinant-antibodies.png)
Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117)
Datasheets and documents
-
SDS download
-
Datasheet download
Certificate of Compliance
References (28)
ab195117 has been referenced in 28 publications.
- Tanaka H et al. YAP-dependent necrosis occurs in early stages of Alzheimer's disease and regulates mouse model pathology. Nat Commun 11:507 (2020). PubMed: 31980612
- Duan X et al. Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation. Cell Death Dis 11:134 (2020). PubMed: 32075957
- Wu YH et al. Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation. Cell Death Dis 11:305 (2020). PubMed: 32366830
- Liu J et al. Inhibition of GSK3ß and RIP1K Attenuates Glial Scar Formation Induced by Ischemic Stroke via Reduction of Inflammatory Cytokine Production. Front Pharmacol 11:812 (2020). PubMed: 32595496
- Liu X et al. Pharmacological activation of CB2 receptor protects against ethanol-induced myocardial injury related to RIP1/RIP3/MLKL-mediated necroptosis. Mol Cell Biochem 474:1-14 (2020). PubMed: 32681290